Chemplast sanmar Limited has formally notified stock exchanges about an upcoming board meeting to review and approve its third-quarter financial performance for fiscal year 2026. The meeting represents a key milestone in the company's quarterly reporting cycle and regulatory compliance obligations.

Board Meeting Details

The board of directors will convene on February 7, 2026, to deliberate on several critical matters related to the company's financial performance. The primary agenda focuses on reviewing and approving comprehensive financial statements for the recent reporting period.

Financial Results Scope

The board will consider and approve multiple categories of financial statements during the scheduled meeting. These documents will provide stakeholders with comprehensive insights into the company's operational and financial performance across different organizational structures.

The meeting agenda includes:

• Unaudited standalone financial results for the quarter and nine months ended December 31, 2025
• Unaudited consolidated financial results for the same period
• Limited review report accompanying the financial statements
• Formal approval and recording of all financial documents

Trading Window Restrictions

Chemplast Sanmar Limited has implemented trading restrictions in accordance with insider trading prevention regulations. The company's Code of Conduct for Prevention of Insider Trading governs these restrictions under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The trading window closure extends until two clear trading days after the communication of financial results to stock exchanges, ensuring compliance with regulatory requirements and maintaining market integrity.

Regulatory Compliance

The announcement demonstrates Chemplast Sanmar Limited's commitment to transparent corporate governance and regulatory adherence. The company has formally communicated with both BSE Limited and National Stock Exchange of India Limited, providing advance notice of the board meeting as required under applicable regulations.

The notification was signed by M Raman Mahadevan, Company Secretary and Compliance Officer, confirming the company's systematic approach to regulatory compliance and stakeholder communication.

Chemplast Sanmar Limited's Board of Directors has approved a comprehensive leadership transition plan during its meeting held on January 10, 2026. The decisions, made following recommendations from the Nomination and Remuneration Committee, include key changes in the Managing Director position and the reappointment of independent directors.

Managing Director Transition

The board approved a structured transition for the Managing Director role, addressing the current MD's desire to step down at the end of the financial year.

Ramkumar Shankar, who has served as Managing Director since February 1, 2021, expressed his desire to be relieved from the position at the close of the current financial year 2025-26. To ensure continuity, the board reappointed him for an additional two months from February 1, 2026, to March 31, 2026.

New Managing Director Appointment

S Ganeshkumar will assume the role of Managing Director for three years starting April 1, 2026. The 57-year-old executive brings extensive experience from his current role as CEO and Managing Director of TCI Sanmar Chemicals S.A.E., Egypt, since February 23, 2022.

Professional Background

Ganeshkumar's career spans multiple industries and leadership roles:

• Current Role: CEO and Managing Director, TCI Sanmar Chemicals S.A.E., Egypt (2022-present)
• Previous Positions: President and COO, Raymond Limited Lifestyle Business (2020-2022); CEO Global Operations, JK Files (India) Limited (2016-2020)
• Earlier Experience: Managing Director, Arysta Life Science India Limited (2013-2016); Director, Mosaic India Private Limited (2002-2013)

Independent Directors Reappointment

The board approved the reappointment of four independent directors for their second consecutive five-year terms, effective April 26, 2026.

Key Director Profiles

Aditya Jain (65 years) serves as Chairman of the Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Risk Management Committee. He is the Chairman and Editorial Director of IMA India, an economic and business research company he established in 1994.

Sanjay Vijay Bhandarkar (57 years) brings over three decades of corporate finance and investment banking experience. He previously led Rothschild India's business and currently serves on the boards of major listed companies including Tata Consultancy Services Limited and The Tata Power Company Limited.

Dr Lakshmi Vijayakumar (70 years) is the founder of SNEHA, an NGO for suicide prevention, and serves as Head of Department of Psychiatry at Voluntary Health Services, Chennai. She is a member of WHO's International Network for Suicide Research and Prevention.

Prasad Raghava Menon (79 years) holds a B.Tech in Chemical Engineering from IIT Kharagpur and brings over 50 years of experience across chemical and power industries, including leadership roles at ICI India, Tata Chemicals, and Tata Power.

Meeting Details and Compliance

The board meeting commenced at 11:30 AM and concluded at 12:10 PM on January 10, 2026. All appointed directors have confirmed they are not debarred from holding directorship by SEBI, Ministry of Corporate Affairs, or any other regulatory authority. The appointments are subject to shareholder approval and other required regulatory approvals.